Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manousos Makridakis

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Molecular & Cellular Proteomics : MCP|December 14, 2011
Profilin 1 is a potential biomarker for bladder cancer aggressivenessJerome Zoidakis, Manousos Makridakis, Panagiotis G Zerefos, et al.
Cancers|August 12, 2022
Proteomic Analysis of Prostate Cancer FFPE Samples Reveals Markers of Disease Progression and AggressivenessVasiliki Lygirou, Konstantinos Fasoulakis, Rafael Stroggilos, et al.
The Journal of Biological Chemistry|March 19, 2020
A systematic re-examination of processing of MHCI-bound antigenic peptide precursors by endoplasmic reticulum aminopeptidase 1George Mavridis, Richa Arya, Alexander Domnick, et al.
Plos One|September 3, 2015
Comparative Analysis of Label-Free and 8-Plex iTRAQ Approach for Quantitative Tissue Proteomic AnalysisAgnieszka Latosinska, Konstantinos Vougas, Manousos Makridakis, et al.
Communications Biology|March 14, 2023
Quantitative proteomic landscape of unstable atherosclerosis identifies molecular signatures and therapeutic targets for plaque stabilizationYung-Chih Chen, Meaghan Smith, Ya-Lan Ying, et al.
Biomed Research International|March 7, 2017
Cervical Cancer Cell Line Secretome Highlights the Roles of Transforming Growth Factor-Beta-Induced Protein ig-h3, Peroxiredoxin-2, and NRF2 on Cervical CarcinogenesisGeorgia Kontostathi, Jerome Zoidakis, Manousos Makridakis, et al.
Proteomics. Clinical Applications|April 4, 2018
Comparison of Urine and Plasma Peptidome Indicates Selectivity in Renal Peptide HandlingPedro Magalhães, Claudia Pontillo, Martin Pejchinovski, et al.
Cancers|February 25, 2023
Mass Spectrometry-Based Biomarkers to Detect Prostate Cancer: A Multicentric Study Based on Non-Invasive Urine Collection without Prior Digital Rectal ExaminationMaria Frantzi, Zoran Culig, Isabel Heidegger, et al.
Oncotarget|September 30, 2016
Silencing of Profilin-1 suppresses cell adhesion and tumor growth via predicted alterations in integrin and Ca2+ signaling in T24M-based bladder cancer modelsMaria Frantzi, Zoi Klimou, Manousos Makridakis, et al.
JCI Insight|September 23, 2021
NETs decorated with bioactive IL-33 infiltrate inflamed tissues and induce IFN-α production in patients with SLESpiros Georgakis, Katerina Gkirtzimanaki, Garyfalia Papadaki, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Molecular & Cellular Proteomics : MCP|December 14, 2011
Profilin 1 is a potential biomarker for bladder cancer aggressivenessJerome Zoidakis, Manousos Makridakis, Panagiotis G Zerefos, et al.
Cancers|August 12, 2022
Proteomic Analysis of Prostate Cancer FFPE Samples Reveals Markers of Disease Progression and AggressivenessVasiliki Lygirou, Konstantinos Fasoulakis, Rafael Stroggilos, et al.
The Journal of Biological Chemistry|March 19, 2020
A systematic re-examination of processing of MHCI-bound antigenic peptide precursors by endoplasmic reticulum aminopeptidase 1George Mavridis, Richa Arya, Alexander Domnick, et al.
Plos One|September 3, 2015
Comparative Analysis of Label-Free and 8-Plex iTRAQ Approach for Quantitative Tissue Proteomic AnalysisAgnieszka Latosinska, Konstantinos Vougas, Manousos Makridakis, et al.
Communications Biology|March 14, 2023
Quantitative proteomic landscape of unstable atherosclerosis identifies molecular signatures and therapeutic targets for plaque stabilizationYung-Chih Chen, Meaghan Smith, Ya-Lan Ying, et al.
Biomed Research International|March 7, 2017
Cervical Cancer Cell Line Secretome Highlights the Roles of Transforming Growth Factor-Beta-Induced Protein ig-h3, Peroxiredoxin-2, and NRF2 on Cervical CarcinogenesisGeorgia Kontostathi, Jerome Zoidakis, Manousos Makridakis, et al.
Proteomics. Clinical Applications|April 4, 2018
Comparison of Urine and Plasma Peptidome Indicates Selectivity in Renal Peptide HandlingPedro Magalhães, Claudia Pontillo, Martin Pejchinovski, et al.
Cancers|February 25, 2023
Mass Spectrometry-Based Biomarkers to Detect Prostate Cancer: A Multicentric Study Based on Non-Invasive Urine Collection without Prior Digital Rectal ExaminationMaria Frantzi, Zoran Culig, Isabel Heidegger, et al.
Oncotarget|September 30, 2016
Silencing of Profilin-1 suppresses cell adhesion and tumor growth via predicted alterations in integrin and Ca2+ signaling in T24M-based bladder cancer modelsMaria Frantzi, Zoi Klimou, Manousos Makridakis, et al.
JCI Insight|September 23, 2021
NETs decorated with bioactive IL-33 infiltrate inflamed tissues and induce IFN-α production in patients with SLESpiros Georgakis, Katerina Gkirtzimanaki, Garyfalia Papadaki, et al.
Pageof 9